The present clinical study was undertaken to determine whether the expression of ER, PgR, HER2, P-gp, MRP, GST-pi and Topo-II could affect the pathologic response of primary breast tumors to three different preoperative chemotherapy regimens including DEC, VFC and EFC. Here, PGR is linked to breast neoplasm.